Orbimed Asia leads $19m round in Chinese biotech startup InventisBio

Orbimed Asia leads $19m round in Chinese biotech startup InventisBio

Photo: Pixabay

Shanghai-headquartered biotech startup InventisBio has raised $19 million in its Series B round of funding led by Orbimed Asia Partners, a healthcare-focused investment firm, the company said in a release.

The round also saw participation from China’s Lilly Asia Ventures (LAV).

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter